Logo image of BLBD

BLUE BIRD CORP (BLBD) Stock Fundamental Analysis

NASDAQ:BLBD - Nasdaq - US0953061068 - Common Stock

42.06  +1.1 (+2.69%)

After market: 39.96 -2.1 (-4.99%)

Fundamental Rating

6

Taking everything into account, BLBD scores 6 out of 10 in our fundamental rating. BLBD was compared to 131 industry peers in the Machinery industry. BLBD has an average financial health and profitability rating. BLBD may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make BLBD suitable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BLBD had positive earnings in the past year.
BLBD had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BLBD reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: BLBD reported negative operating cash flow in multiple years.
BLBD Yearly Net Income VS EBIT VS OCF VS FCFBLBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

BLBD has a Return On Assets of 20.11%. This is amongst the best in the industry. BLBD outperforms 97.64% of its industry peers.
The Return On Equity of BLBD (66.15%) is better than 98.43% of its industry peers.
With an excellent Return On Invested Capital value of 33.55%, BLBD belongs to the best of the industry, outperforming 98.43% of the companies in the same industry.
Industry RankSector Rank
ROA 20.11%
ROE 66.15%
ROIC 33.55%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLBD Yearly ROA, ROE, ROICBLBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

With a decent Profit Margin value of 7.83%, BLBD is doing good in the industry, outperforming 61.42% of the companies in the same industry.
In the last couple of years the Profit Margin of BLBD has grown nicely.
BLBD has a Operating Margin (10.34%) which is in line with its industry peers.
BLBD's Operating Margin has improved in the last couple of years.
BLBD has a Gross Margin of 19.01%. This is in the lower half of the industry: BLBD underperforms 75.59% of its industry peers.
BLBD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.34%
PM (TTM) 7.83%
GM 19.01%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
BLBD Yearly Profit, Operating, Gross MarginsBLBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BLBD is creating value.
Compared to 1 year ago, BLBD has more shares outstanding
BLBD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BLBD has been reduced compared to a year ago.
BLBD Yearly Shares OutstandingBLBD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
BLBD Yearly Total Debt VS Total AssetsBLBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

BLBD has an Altman-Z score of 5.87. This indicates that BLBD is financially healthy and has little risk of bankruptcy at the moment.
BLBD has a Altman-Z score of 5.87. This is in the better half of the industry: BLBD outperforms 77.95% of its industry peers.
The Debt to FCF ratio of BLBD is 1.00, which is an excellent value as it means it would take BLBD, only 1.00 years of fcf income to pay off all of its debts.
BLBD's Debt to FCF ratio of 1.00 is amongst the best of the industry. BLBD outperforms 89.76% of its industry peers.
A Debt/Equity ratio of 0.56 indicates that BLBD is somewhat dependend on debt financing.
BLBD has a worse Debt to Equity ratio (0.56) than 61.42% of its industry peers.
Although BLBD does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 1
Altman-Z 5.87
ROIC/WACC3.47
WACC9.66%
BLBD Yearly LT Debt VS Equity VS FCFBLBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

A Current Ratio of 1.37 indicates that BLBD should not have too much problems paying its short term obligations.
With a Current ratio value of 1.37, BLBD is not doing good in the industry: 80.31% of the companies in the same industry are doing better.
A Quick Ratio of 0.83 indicates that BLBD may have some problems paying its short term obligations.
The Quick ratio of BLBD (0.83) is worse than 78.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.83
BLBD Yearly Current Assets VS Current LiabilitesBLBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

6

3. Growth

3.1 Past

BLBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 225.23%, which is quite impressive.
BLBD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.38% yearly.
BLBD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.93%.
The Revenue has been growing slightly by 5.74% on average over the past years.
EPS 1Y (TTM)225.23%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%16.67%
Revenue 1Y (TTM)18.93%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%15.6%

3.2 Future

The Earnings Per Share is expected to grow by 9.01% on average over the next years. This is quite good.
Based on estimates for the next years, BLBD will show a quite strong growth in Revenue. The Revenue will grow by 8.93% on average per year.
EPS Next Y14.54%
EPS Next 2Y14.05%
EPS Next 3Y9.01%
EPS Next 5YN/A
Revenue Next Year10.2%
Revenue Next 2Y9.39%
Revenue Next 3Y8.93%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BLBD Yearly Revenue VS EstimatesBLBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
BLBD Yearly EPS VS EstimatesBLBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 3 4

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.09, the valuation of BLBD can be described as correct.
Based on the Price/Earnings ratio, BLBD is valued cheaply inside the industry as 88.98% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.29. BLBD is valued rather cheaply when compared to this.
BLBD is valuated reasonably with a Price/Forward Earnings ratio of 10.55.
94.49% of the companies in the same industry are more expensive than BLBD, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 24.44. BLBD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.09
Fwd PE 10.55
BLBD Price Earnings VS Forward Price EarningsBLBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLBD indicates a rather cheap valuation: BLBD is cheaper than 82.68% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BLBD indicates a rather cheap valuation: BLBD is cheaper than 88.98% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.16
EV/EBITDA 8.6
BLBD Per share dataBLBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

BLBD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of BLBD may justify a higher PE ratio.
PEG (NY)0.83
PEG (5Y)0.74
EPS Next 2Y14.05%
EPS Next 3Y9.01%

0

5. Dividend

5.1 Amount

BLBD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUE BIRD CORP

NASDAQ:BLBD (1/21/2025, 8:00:00 PM)

After market: 39.96 -2.1 (-4.99%)

42.06

+1.1 (+2.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-25 2024-11-25/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners89.58%
Inst Owner Change-0.2%
Ins Owners0.05%
Ins Owner Change2.69%
Market Cap1.36B
Analysts82.86
Price Target57.57 (36.88%)
Short Float %16.71%
Short Ratio6.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)44.68%
Min EPS beat(2)15.25%
Max EPS beat(2)74.11%
EPS beat(4)4
Avg EPS beat(4)76.87%
Min EPS beat(4)15.25%
Max EPS beat(4)138.23%
EPS beat(8)8
Avg EPS beat(8)80.41%
EPS beat(12)9
Avg EPS beat(12)-106.57%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.67%
Min Revenue beat(2)-0.54%
Max Revenue beat(2)3.87%
Revenue beat(4)3
Avg Revenue beat(4)7.54%
Min Revenue beat(4)-0.54%
Max Revenue beat(4)13.65%
Revenue beat(8)7
Avg Revenue beat(8)7.62%
Revenue beat(12)10
Avg Revenue beat(12)10.01%
Revenue beat(16)10
Avg Revenue beat(16)4.14%
PT rev (1m)0%
PT rev (3m)-3.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)61.01%
EPS NY rev (1m)0%
EPS NY rev (3m)7.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.54%
Valuation
Industry RankSector Rank
PE 12.09
Fwd PE 10.55
P/S 1.01
P/FCF 14.16
P/OCF 12.22
P/B 8.51
P/tB 13.97
EV/EBITDA 8.6
EPS(TTM)3.48
EY8.27%
EPS(NY)3.99
Fwd EY9.48%
FCF(TTM)2.97
FCFY7.06%
OCF(TTM)3.44
OCFY8.19%
SpS41.75
BVpS4.94
TBVpS3.01
PEG (NY)0.83
PEG (5Y)0.74
Profitability
Industry RankSector Rank
ROA 20.11%
ROE 66.15%
ROCE 48.22%
ROIC 33.55%
ROICexc 60.11%
ROICexgc 98.05%
OM 10.34%
PM (TTM) 7.83%
GM 19.01%
FCFM 7.11%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y220.13%
ROICexcg growth 5Y10.5%
ROICexc growth 3Y207.87%
ROICexc growth 5Y19.73%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
F-Score8
Asset Turnover2.57
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 1
Debt/EBITDA 0.58
Cap/Depr 102.99%
Cap/Sales 1.13%
Interest Coverage 14.03
Cash Conversion 72.08%
Profit Quality 90.81%
Current Ratio 1.37
Quick Ratio 0.83
Altman-Z 5.87
F-Score8
WACC9.66%
ROIC/WACC3.47
Cap/Depr(3y)67.41%
Cap/Depr(5y)84.95%
Cap/Sales(3y)0.9%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)225.23%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%16.67%
EPS Next Y14.54%
EPS Next 2Y14.05%
EPS Next 3Y9.01%
EPS Next 5YN/A
Revenue 1Y (TTM)18.93%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%15.6%
Revenue Next Year10.2%
Revenue Next 2Y9.39%
Revenue Next 3Y8.93%
Revenue Next 5YN/A
EBIT growth 1Y166.58%
EBIT growth 3Y177.79%
EBIT growth 5Y26.04%
EBIT Next Year39.03%
EBIT Next 3Y15.86%
EBIT Next 5YN/A
FCF growth 1Y-13.97%
FCF growth 3YN/A
FCF growth 5Y36.54%
OCF growth 1Y-7.35%
OCF growth 3YN/A
OCF growth 5Y14.81%